Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study.

Adult growth hormone deficiency (GHD), a condition characterized by increased oxidative stress, is related to augmented cardiovascular, metabolic and oncological risk. A case-control observational study has been performed to evaluate DNA oxidative damage analysing the production of thymidine-glycol...

Full description

Bibliographic Details
Main Authors: Antonio Mancini, Francesco Guidi, Carmine Bruno, Flavia Angelini, Edoardo Vergani, Paola Lanza, Alvaro Mordente, Elisabetta Meucci, Andrea Silvestrini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0248971
_version_ 1818743031684136960
author Antonio Mancini
Francesco Guidi
Carmine Bruno
Flavia Angelini
Edoardo Vergani
Paola Lanza
Alvaro Mordente
Elisabetta Meucci
Andrea Silvestrini
author_facet Antonio Mancini
Francesco Guidi
Carmine Bruno
Flavia Angelini
Edoardo Vergani
Paola Lanza
Alvaro Mordente
Elisabetta Meucci
Andrea Silvestrini
author_sort Antonio Mancini
collection DOAJ
description Adult growth hormone deficiency (GHD), a condition characterized by increased oxidative stress, is related to augmented cardiovascular, metabolic and oncological risk. A case-control observational study has been performed to evaluate DNA oxidative damage analysing the production of thymidine-glycol in lymphocytes and its correlation with plasma antioxidant levels, evaluated as Total Antioxidant Capacity (TAC). GHD was diagnosed using GHRH 50μg iv+arginine 0,5 g/Kg test, with peak GH response <9 μg/L when BMI was <30 kg/m2 or <4 μg/L when BMI was >30 kg/m2. Three groups were identified: total GHD (n = 16), partial GHD (n = 11), and controls (n = 12). Thymidine-glycol, TAC and IGF-1 have been determined respectively in lymphocytes, plasma and serum samples. When considering thymidine-glycol, we found a significant difference between total vs partial GHD and controls. Unexpectedly thymidine-glycol was lower in total GHD, also accompanied with a significant increase in plasmatic TAC. Our results showed that in adult GHD condition, the production of antioxidant species, in response to increased oxidative stress, could exert a protective effect on thymidine-glycol formation, and consequently on DNA intracellular damages. This pilot study could be inserted in the complex scenario of oxidative damage of GHD, a subtle, yet poorly defined condition, worthy of further insights.
first_indexed 2024-12-18T02:21:57Z
format Article
id doaj.art-6c4285331adc41eebf0faece072636d0
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-18T02:21:57Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-6c4285331adc41eebf0faece072636d02022-12-21T21:24:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01164e024897110.1371/journal.pone.0248971Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study.Antonio ManciniFrancesco GuidiCarmine BrunoFlavia AngeliniEdoardo VerganiPaola LanzaAlvaro MordenteElisabetta MeucciAndrea SilvestriniAdult growth hormone deficiency (GHD), a condition characterized by increased oxidative stress, is related to augmented cardiovascular, metabolic and oncological risk. A case-control observational study has been performed to evaluate DNA oxidative damage analysing the production of thymidine-glycol in lymphocytes and its correlation with plasma antioxidant levels, evaluated as Total Antioxidant Capacity (TAC). GHD was diagnosed using GHRH 50μg iv+arginine 0,5 g/Kg test, with peak GH response <9 μg/L when BMI was <30 kg/m2 or <4 μg/L when BMI was >30 kg/m2. Three groups were identified: total GHD (n = 16), partial GHD (n = 11), and controls (n = 12). Thymidine-glycol, TAC and IGF-1 have been determined respectively in lymphocytes, plasma and serum samples. When considering thymidine-glycol, we found a significant difference between total vs partial GHD and controls. Unexpectedly thymidine-glycol was lower in total GHD, also accompanied with a significant increase in plasmatic TAC. Our results showed that in adult GHD condition, the production of antioxidant species, in response to increased oxidative stress, could exert a protective effect on thymidine-glycol formation, and consequently on DNA intracellular damages. This pilot study could be inserted in the complex scenario of oxidative damage of GHD, a subtle, yet poorly defined condition, worthy of further insights.https://doi.org/10.1371/journal.pone.0248971
spellingShingle Antonio Mancini
Francesco Guidi
Carmine Bruno
Flavia Angelini
Edoardo Vergani
Paola Lanza
Alvaro Mordente
Elisabetta Meucci
Andrea Silvestrini
Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study.
PLoS ONE
title Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study.
title_full Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study.
title_fullStr Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study.
title_full_unstemmed Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study.
title_short Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by growth hormone deficiency? A pilot study.
title_sort can plasma antioxidants prevent dna damage in oxidative stress condition induced by growth hormone deficiency a pilot study
url https://doi.org/10.1371/journal.pone.0248971
work_keys_str_mv AT antoniomancini canplasmaantioxidantspreventdnadamageinoxidativestressconditioninducedbygrowthhormonedeficiencyapilotstudy
AT francescoguidi canplasmaantioxidantspreventdnadamageinoxidativestressconditioninducedbygrowthhormonedeficiencyapilotstudy
AT carminebruno canplasmaantioxidantspreventdnadamageinoxidativestressconditioninducedbygrowthhormonedeficiencyapilotstudy
AT flaviaangelini canplasmaantioxidantspreventdnadamageinoxidativestressconditioninducedbygrowthhormonedeficiencyapilotstudy
AT edoardovergani canplasmaantioxidantspreventdnadamageinoxidativestressconditioninducedbygrowthhormonedeficiencyapilotstudy
AT paolalanza canplasmaantioxidantspreventdnadamageinoxidativestressconditioninducedbygrowthhormonedeficiencyapilotstudy
AT alvaromordente canplasmaantioxidantspreventdnadamageinoxidativestressconditioninducedbygrowthhormonedeficiencyapilotstudy
AT elisabettameucci canplasmaantioxidantspreventdnadamageinoxidativestressconditioninducedbygrowthhormonedeficiencyapilotstudy
AT andreasilvestrini canplasmaantioxidantspreventdnadamageinoxidativestressconditioninducedbygrowthhormonedeficiencyapilotstudy